These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 12967941
1. Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents. Croci T, Landi M, Galzin AM, Marini P. Br J Pharmacol; 2003 Sep; 140(1):115-22. PubMed ID: 12967941 [Abstract] [Full Text] [Related]
2. Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors. Bátkai S, Pacher P, Járai Z, Wagner JA, Kunos G. Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H595-600. PubMed ID: 15059774 [Abstract] [Full Text] [Related]
5. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner. Zádor F, Lénárt N, Csibrány B, Sántha M, Molnár M, Tuka B, Samavati R, Klivényi P, Vécsei L, Marton A, Vizler C, Nagy GM, Borsodi A, Benyhe S, Páldy E. Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673 [Abstract] [Full Text] [Related]
8. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior. Duarte C, Alonso R, Bichet N, Cohen C, Soubrié P, Thiébot MH. Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354 [Abstract] [Full Text] [Related]
9. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Griebel G, Stemmelin J, Scatton B. Biol Psychiatry; 2005 Feb 01; 57(3):261-7. PubMed ID: 15691527 [Abstract] [Full Text] [Related]
10. Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat. Liu WJ, Jin HY, Park JH, Baek HS, Park TS. Eur J Pharmacol; 2010 Jul 10; 637(1-3):70-6. PubMed ID: 20406631 [Abstract] [Full Text] [Related]
17. Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice. Fukumoto K, Naito Y, Takagi T, Yamada S, Horie R, Inoue K, Harusato A, Hirata I, Omatsu T, Mizushima K, Hirai Y, Yoshida N, Uchiyama K, Ishikawa T, Handa O, Konishi H, Wakabayashi N, Yagi N, Kokura S, Ichikawa H, Kita M, Yoshikawa T. Int J Mol Med; 2011 Mar 10; 27(3):353-9. PubMed ID: 21249312 [Abstract] [Full Text] [Related]
19. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. Tambaro S, Casu MA, Mastinu A, Lazzari P. Eur J Pharmacol; 2014 Apr 15; 729():67-74. PubMed ID: 24561047 [Abstract] [Full Text] [Related]
20. Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway. Huang NL, Juang JM, Wang YH, Hsueh CH, Liang YJ, Lin JL, Tsai CT, Lai LP. Acta Pharmacol Sin; 2010 Nov 15; 31(11):1447-53. PubMed ID: 20953204 [Abstract] [Full Text] [Related] Page: [Next] [New Search]